mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
AZD7762 |
GDSC1000 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.1 |